Cargando…
Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks
BACKGROUND: Therapies available for late stage prostate cancer (PCa) patients are limited and mostly palliative. The necessary development of unexplored therapeutic options relies on a deeper knowledge of molecular mechanisms leading to cancer progression. Redox signals are known to modulate the int...
Autores principales: | Cornelius, Julian, Cavarretta, Ilaria, Pozzi, Edoardo, Lavorgna, Giovanni, Locatelli, Irene, Tempio, Tiziana, Montorsi, Francesco, Mattei, Agostino, Sitia, Roberto, Salonia, Andrea, Anelli, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039598/ https://www.ncbi.nlm.nih.gov/pubmed/33850746 http://dx.doi.org/10.21037/tau-20-1025 |
Ejemplares similares
-
A virtuous cycle operated by ERp44 and ERGIC-53 guarantees proteostasis in the early secretory compartment
por: Tempio, Tiziana, et al.
Publicado: (2021) -
Zinc regulates ERp44-dependent protein quality control in the early secretory pathway
por: Watanabe, Satoshi, et al.
Publicado: (2019) -
Endoplasmic Reticulum Chaperones and Oxidoreductases: Critical Regulators of Tumor Cell Survival and Immunorecognition
por: Gutiérrez, Tomás, et al.
Publicado: (2014) -
MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha
por: Chen, Gang, et al.
Publicado: (2022) -
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
por: Garg, Abhishek D, et al.
Publicado: (2014)